1. The Role of Macronutrients, Micronutrients and Flavonoid Polyphenols in the Prevention and Treatment of Osteoporosis
   Monika Martiniakova et al, 2022, Nutrients CrossRef
2. Advances in pathogenesis and therapeutic strategies for osteoporosis
   Shasha Song et al, 2022, Pharmacology & Therapeutics CrossRef
3. TMT‐based proteomics analysis to screen potential biomarkers of Achyranthis Bidentatae Radix for osteoporosis in rats
   Liu Yang et al, 2022, Biomedical Chromatography CrossRef
4. Niloticin inhibits osteoclastogenesis by blocking RANKL–RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways
   Huanhuan Xu et al, 2022, Biomedicine & Pharmacotherapy CrossRef
5. Impact of the Malnutrition on Mortality in Patients With Osteoporosis: A Cohort Study From NHANES 2005-2010
   Xiaohui Shangguan et al, 2022, Front. Nutr. CrossRef
6. The “Three in One” Bone Repair Strategy for Osteoporotic Fractures
   Xiao Chen et al, 2022, Front. Endocrinol. CrossRef
7. Dietary Collagen Hydrolysates Retard Estrogen Deficiency-Induced Bone Loss through Blocking Osteoclastic Activation and Enhancing Osteoblastic Matrix Mineralization
   Soo-Il Kim et al, 2022, Biomedicines CrossRef
8. Effect of Anti-Osteoporotic Treatments on Circulating and Bone MicroRNA Patterns in Osteopenic ZDF Rats
   David Carro Vázquez et al, 2022, IJMS CrossRef
9. A Predictive Model for Abnormal Bone Density in Male Underground Coal Mine Workers
   Ziwei Zheng et al, 2022, IJERPH CrossRef
10. The roles of circRNA-miRNA-mRNA networks in the development and treatment of osteoporosis.
    Manqi Gao et al, 2022, Front Endocrinol (Lausanne) CrossRef
11. Comparison of Pharmacokinetic Profiles of 14 Major Bioactive Components in Normal and Arthritic Model Rats after Oral Administration of Angelicae pubescentis Radix by UPLC-MS/MS
    Ajiao Hou et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
12. Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα–NF-κB p65 Complex
    Junchun Chen et al, 2022, Front. Pharmacol. CrossRef
13. A bibliometrics visualization analysis and hotspots prediction for natural product on osteoporosis research from 2000 to 2021
    Ajiao Hou et al, 2022, Journal of Future Foods CrossRef
14. Effect of Taraxaci Herba on Bone Loss in an OVX-Induced Model through the Regulation of Osteoclast Differentiation
    Jun Heo et al, 2022, Nutrients CrossRef
15. Epigallocatechin-3-gallate inhibits osteoclastic differentiation by modulating mitophagy and mitochondrial functions
    Jaganmay Sarkar et al, 2022, Cell Death Dis CrossRef
16. 1,3-Dibenzyl-5-Fluorouracil Prevents Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Differentiation
    Hyoeun Jeon et al, 2022, Immune Netw CrossRef
17. Comparing the effectiveness of type of the traditional Chinese exercises, frequency, intensity, time in osteoporosis: a protocol for systematic evaluation and network meta-analysis of randomised controlled trials
    Haifeng Chen et al, 2022, BMJ Open CrossRef
18. Gut microbiota and fecal metabolic signatures in rat models of disuse-induced osteoporosis
    Xiaochen Qiao et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
19. Inferring Bacterial Community Interactions and Functionalities Associated with Osteopenia and Osteoporosis in Taiwanese Postmenopausal Women
    Yi-Jie Kuo et al, 2023, Microorganisms CrossRef
20. Bioactivity, Molecular Mechanism, and Targeted Delivery of Flavonoids for Bone Loss
    Ashish Ranjan Sharma et al, 2023, Nutrients CrossRef
21. Genus Equisetum L: Taxonomy, toxicology, phytochemistry and pharmacology
    J. Sureshkumar et al, 2023, Journal of Ethnopharmacology CrossRef
22. Aortic carboxypeptidase‐like protein, a putative myokine, stimulates the differentiation and survival of bone‐forming osteoblasts
    Hanjun Kim et al, 2023, The FASEB Journal CrossRef
23. Biological therapy for osteoporosis - solving clinical problems - a case report
    Tanja Jankovic et al, 2022, Med pregl CrossRef
24. Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis
    Zhong-Hua Chen et al, 2023, Materials Today Bio CrossRef
25. MiR-210 promotes bone formation in ovariectomized rats by regulating osteogenic/adipogenic differentiation of bone marrow mesenchymal stem cells through downregulation of EPHA2
    Lijue Ren et al, 2023, J Orthop Surg Res CrossRef
26. Isolation and characterization of a novel homopolysaccharide (SFP-1) from Sargassum fusiforme: Promising anti-osteoporosis activity by modulating adipo-osteogenic differentiation
    Luming Deng et al, 2024, Industrial Crops and Products CrossRef
27. What is the evidence for the effect of physical exercise on bone health in menopausal women? An umbrella systematic review
    D. Y. Fausto et al, 2023, Climacteric CrossRef
28. null
    Ryan Daffa Pratama et al, 2023 CrossRef
29. Osteoporosis therapy using nanoparticles: a review
    Soumeia Zeghoud et al, 2024 CrossRef
30. 2,4′-Dihydroxybenzophenone Exerts Bone Formation and Antiosteoporotic Activity by Stimulating the β-Catenin Signaling Pathway
    Mirissa Hewage Dumindu Kavinda et al, 2024, ACS Pharmacol. Transl. Sci. CrossRef
31. Study on the mechanism of naringin in promoting bone differentiation: In vitro and in vivo study
    Xian Li et al, 2024, Heliyon CrossRef
32. Exploring epigenetic strategies for the treatment of osteoporosis
    Sun-Ju Yi et al, 2024, Mol Biol Rep CrossRef
33. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe
    Maria Eleni Chondrogianni et al, 2024, Front. Endocrinol. CrossRef
34. The novel small molecule E0924G dually regulates bone formation and bone resorption through activating the PPARδ signaling pathway to prevent bone loss in ovariectomized rats and senile mice
    Yining Li et al, 2024, Bioorganic Chemistry CrossRef
35. Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss
    Jonathan W. Lewis et al, 2024, Cell Reports Medicine CrossRef
36. Efficacy of Opportunistic Screening with Chest CT in Identifying Osteoporosis and Osteopenia in Patients with T2DM
    Congyang Xue et al, 2024, DMSO CrossRef
37. A comprehensive review and advanced biomolecule-based therapies for osteoporosis
    Maqsood Ali et al, 2024, Journal of Advanced Research CrossRef
38. Nutraceuticals and Functional Foods: A Comprehensive Review of Their Role in Bone Health
    Maria Felicia Faienza et al, 2024, IJMS CrossRef
39. Suppression of bone resorption by Mori Radicis Cortex through NFATc1 and c-Fos signaling-mediated inhibition of osteoclast differentiation
    Sooyeon Hong et al, 2024 CrossRef
40. Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State
    Shengling Hu et al, 2024, Clinical Pharm in Drug Dev CrossRef
41. In vitro and in vivo studies on exogenous polyamines and α-difluoromethylornithine to enhance bone formation and suppress osteoclast differentiation
    Chien-Ching Lee et al, 2024, Amino Acids CrossRef
42. Study of the effect of phytoextract based on rice husk and germ film, green tea on the functional properties of cells involved in bone tissue metabolism
    N. A. Sitnikova et al, 2024, Sibirskij nauchnyj medicinskij zhurnal CrossRef
43. Enhancing osteoporosis treatment using a targeted, sustained-release drug delivery system based on macrocyclic amphiphile
    Gan Luo et al, 2024, International Journal of Pharmaceutics CrossRef
44. Estrogen and estrogen receptors mediate the mechanobiology of bone disease and repair
    Vivian Shi et al, 2024, Bone CrossRef
45. Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex® in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical Trial
    Sofia Sabatelli et al, 2024, IJMS CrossRef
46. Low-molecular-weight estrogenic phytoprotein suppresses osteoporosis development through positive modulation of skeletal estrogen receptors
    John Akrofi Kubi et al, 2024, Bioactive Materials CrossRef
47. Development of a zoledronate-modified functional alginate hydrogel with effects of promoting osteogenesis for potential osteoporosis treatment
    Jieyi Zuo et al, 2024, International Journal of Biological Macromolecules CrossRef
48. Decoding Osteoporosis: Understanding the Disease, Exploring Current and New Therapies and Emerging Targets.
    Dhruvee Patel et al, 2024, Journal of Orthopaedic Reports CrossRef
49. Alendronate-functionalized polymeric micelles target icaritin to bone for mitigating osteoporosis in a rat model
    Xiaoduan Sun et al, 2024, Journal of Controlled Release CrossRef
50. Oral administration of egg white ovotransferrin prevents osteoporosis in ovariectomized rats
    Nan Shang et al, 2024 CrossRef
51. Role of mir-32-3p in the diagnosis and risk assessment of osteoporotic fractures
    Jingda Zhang et al, 2024, J Orthop Surg Res CrossRef
52. The Therapeutic Potential of Osmundacetone for Rheumatoid Arthritis: Effects and Mechanisms on Osteoclastogenesis
    Zirou Wang et al, 2024, European Journal of Pharmacology CrossRef
53. Comparative Analysis of Extracorporeal Shockwave Therapy, Bisphosphonate, and Wharton Jelly-Derived Mesenchymal Stem Cells in Preserving Bone and Cartilage Integrity and Modulating IL31, IL33, and BMP2 in the Cartilage of Ovariectomized Rat Model
    Jai-Hong Cheng et al, 2024, Biomedicines CrossRef
54. Gut-bone axis perturbation: Mechanisms and interventions via gut microbiota as a primary driver of osteoporosis
    Jingyuan Wei et al, 2025, Journal of Orthopaedic Translation CrossRef